0.0001
+0.0001
(0.00%)
At close: January 24 at 3:00:00 PM EST
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
-227.9340
362.3130
241.8700
822.8450
Cost of Revenue
3.2000
--
341.6260
1,206.9600
Gross Profit
-231.1340
362.3130
-99.7560
-384.1150
Operating Expense
1,110.7700
3,786.6050
8,547.3300
3,441.1350
Operating Income
-1,341.9040
-3,424.2920
-8,647.0860
-3,825.2500
Net Non Operating Interest Income Expense
-49.4500
41.9690
-90.4070
-148.8430
Other Income Expense
383.9740
-1,997.9180
12,544.8240
0.9650
Pretax Income
-1,007.3800
-5,380.2410
3,807.3310
-3,973.1280
Tax Provision
--
--
277.0000
--
Net Income Common Stockholders
-1,007.3800
-5,380.2410
3,530.3310
-3,964.6150
Diluted NI Available to Com Stockholders
-1,007.3800
-5,380.2410
3,530.3310
-3,964.6150
Basic EPS
-0.04
-0.07
0.05
-0.06
Diluted EPS
-0.04
-0.07
0.05
-0.06
Basic Average Shares
73,812.6560
74,890.3020
70,464.2800
65,882.9930
Diluted Average Shares
73,812.6560
74,890.3020
70,665.7790
65,882.9930
Total Operating Income as Reported
-1,341.9040
-3,424.2920
-8,647.0860
-3,825.2500
Total Expenses
1,113.9700
3,786.6050
8,888.9560
4,648.0950
Net Income from Continuing & Discontinued Operation
-1,007.3800
-5,380.2410
3,530.3310
-3,964.6150
Normalized Income
-71.0630
-3,353.6840
-5,842.7008
-3,965.5800
Interest Income
34.5040
120.1920
20.2700
18.3450
Interest Expense
83.9540
78.2230
110.6770
167.1880
Net Interest Income
-49.4500
41.9690
-90.4070
-148.8430
EBIT
-923.4260
-5,302.0180
3,918.0080
-3,805.9400
EBITDA
-693.4030
-5,071.4020
4,315.7070
-3,136.9590
Reconciled Cost of Revenue
3.2000
--
237.8640
991.8660
Reconciled Depreciation
230.0230
230.6160
397.6990
668.9810
Net Income from Continuing Operation Net Minority Interest
-1,007.3800
-5,380.2410
3,530.3310
-3,964.6150
Total Unusual Items Excluding Goodwill
-936.3170
-2,026.5570
10,108.4670
0.9650
Total Unusual Items
-936.3170
-2,026.5570
10,108.4670
0.9650
Normalized EBITDA
242.9140
-3,044.8450
-5,792.7600
-3,137.9240
Tax Rate for Calcs
--
--
0.0001
--
Tax Effect of Unusual Items
--
--
735.4352
--
12/31/2020 - 3/5/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MJRX.CN Global Health Clinics Ltd.
0.0100
0.00%
CNADF CanadaBis Capital Inc.
0.0420
+20.00%
HYEX Healthy Extracts Inc.
1.5000
-25.37%
CANQF CanaQuest Medical Corp.
0.0342
+71.00%
RAMM.CN RAMM Pharma Corp.
0.0150
0.00%
CLSH CLS Holdings USA, Inc.
0.0310
+3.33%
PCLOF PharmaCielo Ltd.
0.0700
+4.48%
VIBEF Vibe Growth Corporation
0.0130
-92.78%
GFI.NZ Greenfern Industries Limited
0.0230
-11.54%
AYURF Ayurcann Holdings Corp.
0.0290
+26.09%